These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8625080)

  • 21. Receptors for epidermal growth factor and estradiol in canine mammary tumors.
    Nerurkar VR; Seshadri R; Mulherkar R; Ishwad CS; Lalitha VS; Naik SN
    Int J Cancer; 1987 Aug; 40(2):230-2. PubMed ID: 3610391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro study on the effect of sex steroid and growth factor on growth and laminin, collagen IV, and tissue plasminogen activator production of normal endometrial cells and endometrial cancer cells in culture].
    Ueda M; Ueki M; Tsurunaga T; Yamada T; Okamoto Y; Seiki Y; Iwai E; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1219-26. PubMed ID: 1431434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors.
    Cappelletti V; Brivio M; Miodini P; Granata G; Coradini D; Di Fronzo G
    Tumour Biol; 1988; 9(4):200-11. PubMed ID: 3420376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical study of estradiol, epidermal growth factor, transforming growth factor alpha and epidermal growth factor receptor in endometrial neoplasia.
    Yokoyama Y; Takahashi Y; Hashimoto M; Morishita S; Tamaya T
    Jpn J Clin Oncol; 1996 Dec; 26(6):411-6. PubMed ID: 9001345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of progesterone and tamoxifen on EGF-dependent activation of phospholipid turnover in uterine and breast tumor cells].
    Krasil'nikov MA; Shatskaia VA; Bassalyk LS
    Biokhimiia; 1993 Jun; 58(6):967-74. PubMed ID: 8364119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors.
    Scambia G; Panici PB; Bellantone R; Doglietto GB; Sofo L; Ferrandina G; Ratto C; Bossola M; Crucitti F; Spagnolo LC
    J Surg Oncol; 1991 Nov; 48(3):183-7. PubMed ID: 1943115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidermal growth factor receptor in human breast cancer: correlation with steroid receptors, tumor stage, grading and menopausal status].
    Speiser P; Sliutz G; Zeillinger R; Czerwenka K; Jakesz R; Knogler W; Kury F; Reiner A; Sevelda P; Schneeberger C
    Geburtshilfe Frauenheilkd; 1992 Jun; 52(6):355-9. PubMed ID: 1634099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hormones and epidermal growth factor on the growth of the hormone-responsive 13762NF rat mammary tumor in collagen gel culture.
    Richards JE; Edery M; Osborn RC; Larson LN; Nandi S
    J Natl Cancer Inst; 1986 Apr; 76(4):669-82. PubMed ID: 3007845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of epidermal growth factor receptor and concentrations of epidermal growth factor and melatonin in endometrial carcinoma].
    Dznelashvili N; Kasradze D; Tavartkiladze A
    Georgian Med News; 2014 Oct; (235):17-24. PubMed ID: 25416211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S; Chen X; Lu X; Yu Y; Feng Y
    Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of epidermal growth factor signaling system in the pathogenesis of endometriosis under estrogen deprivation conditions].
    Wang YQ; Yin LR; Guo RM; Sheng W
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jun; 48(6):447-52. PubMed ID: 24103125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR; Bradley SV; Fuchshuber S; Conover CA
    Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial response to sexual steroids as assessed by prostaglandin F(2alpha) output in explant culture and hormone receptor expression.
    Illouz S; Boubli L; Lavaut MN; Allasia C; Charpin C
    Gynecol Obstet Invest; 2000; 50(1):43-9. PubMed ID: 10895028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor and 17beta-estradiol effects on proliferation of a human gastric cancer cell line (AGS).
    Messa C; Russo F; Pricci M; Di Leo A
    Scand J Gastroenterol; 2000 Jul; 35(7):753-8. PubMed ID: 10972181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for direct regulation of epidermal growth factor receptors by steroid hormones in human endometrial cells.
    Taketani Y; Mizuno M
    Hum Reprod; 1991 Nov; 6(10):1365-9. PubMed ID: 1770127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor in NMU-induced mammary tumors in rats.
    Martin G; Cricco G; Davio C; Engel N; Cocca C; Rivera E; Bergoc R
    Breast Cancer Res Treat; 1998 Mar; 48(2):175-85. PubMed ID: 9596489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The endocrine disruptor bisphenol A promotes nuclear ERRĪ³ translocation, facilitating cell proliferation of Grade I endometrial cancer cells via EGF-dependent and EGF-independent pathways.
    Yaguchi T
    Mol Cell Biochem; 2019 Feb; 452(1-2):41-50. PubMed ID: 30022450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease in estradiol-stimulated progesterone receptor production in MCF-7 cells by epidermal growth factor and possible clinical implication for paracrine-regulated breast cancer growth.
    Cormier EM; Wolf MF; Jordan VC
    Cancer Res; 1989 Feb; 49(3):576-80. PubMed ID: 2783381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.
    Daniel AR; Qiu M; Faivre EJ; Ostrander JH; Skildum A; Lange CA
    Steroids; 2007 Feb; 72(2):188-201. PubMed ID: 17173941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.